(RTTNews) - Biopharmaceutical company Phathom Pharmaceuticals, Inc. (PHAT) announced on Friday that Mumbai, India-based BDR Pharmaceuticals International Pvt. Ltd. has filed a lawsuit against the U.S. Food and Drug Administration or FDA, challenging the agency's decision to grant
Kenya confirmed its first imported case of Bundibugyo Ebola virus disease on October 6 after a Kenyan who had been living in the Democratic Republic of Congo travelled through Uganda to Nairobi.
Hanmi Pharmaceutical has secured an international nonproprietary name (INN) for HM15275, its next-generation obesity drug candidate, which will now be known as zantrutide.
MDCAN has urged Nigerian hospitals to activate isolation centres and boost surveillance following the confirmation of an Ebola Bundibugyo virus case in the Read More…